Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02440711 · ClinicalTrials.gov registry record · NA

Evaluation of a Modified Running-specific Prosthetic Foot

A NA study of Transtibial Amputation, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT02440711 is a NA study of Transtibial Amputation that has completed, run by University of Washington. The registered enrollment target is 36 participants, above the 28-participant average among 4 other Transtibial Amputation trials with a reported enrollment target (29% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02440711, a NA study of Transtibial Amputation, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to evaluate endurance, walking performance, mobility, and perceived exertion of transtibial prosthesis users (i.e., study participants) walking with a conventional energy storing prosthetic foot (ESF) and a novel modified running-specific prosthesis (mRSF). A randomized cross-over study will be conducted to determine if the mRSF provides superior performance to the ESF, which is commonly prescribed to most active individuals with lower limb amputation.

Conditions Studied

Interventions

  • DEVICE Energy storing foot (ESF)
  • DEVICE Modified running specific foot (mRSF)

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2015-05
Est. Completion 2018-03
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT02440711

The ClinicalTrials.gov registry entry for NCT02440711 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 28-participant average among 4 other Transtibial Amputation trials with a reported enrollment target (29% higher). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Transtibial Amputation appearing as the primary indexed condition, and to 2 interventions - of which Energy storing foot (ESF) is the first listed.

NCT02440711 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT02440711 about?

NCT02440711 is a clinical study titled "Evaluation of a Modified Running-specific Prosthetic Foot". The goal of this study is to evaluate endurance, walking performance, mobility, and perceived exertion of transtibial prosthesis users (i.e., study participants) walking with a conventional energy storing prosthetic foot (ESF) and a novel modified running-specific prosthesis (mRSF). A randomized cro...

What is the current status of trial NCT02440711?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2015-05. Estimated completion is 2018-03.

What conditions does trial NCT02440711 study?

This clinical trial studies the following conditions: Transtibial Amputation.

What interventions are being tested in trial NCT02440711?

The interventions under investigation include: Energy storing foot (ESF) (DEVICE), Modified running specific foot (mRSF) (DEVICE).

Who is sponsoring clinical trial NCT02440711?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02440711 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Transtibial Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.